Evidence map›Paper›PMID 38601220›Full record

ArticleJournal of maxillofacial and oral surgery2024

Cone Beam-CT-Based Bone Volume Assessments of Alveolar Synthetic Bone Graft GlassBONE™ in Cleft Lip and Palate Patients: A Retrospective Study.

C Philip-Alliez, L Fievet, N Serratrice, M Seiler, M Le Gall, C Charavet, J H Catherine

Open access · greenAbstract read
In one paragraph

Article in Journal of maxillofacial and oral surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

C Philip-AlliezDepartment of Orthodontics, La Timone Hospital (Assistance Publique - Hôpitaux de Marseille), Marseille, France.
L FievetDepartment of Pediatric Surgery, CHU La Réunion, Saint-Denis, France.
N SerratriceDepartment of Neurosurgery, La Timone Hospital (Assistance Publique - Hôpitaux de Marseille), Marseille, France.ORCID 0000-0002-9419-1463
M SeilerDepartment of Orthodontics, La Timone Hospital (Assistance Publique - Hôpitaux de Marseille), Marseille, France.
M Le GallDepartment of Orthodontics, La Timone Hospital (Assistance Publique - Hôpitaux de Marseille), Marseille, France.
C CharavetDépartement d'Orthodontie, Faculté de Chirurgie Dentaire, Université Côte d'Azur, Nice, France.
J H CatherineDepartment of Oral Surgery, La Timone Hospital (Assistance Publique - Hôpitaux de Marseille), Marseille, France.
Assistance Publique Hôpitaux de Marseille · FRAix-Marseille Université · FRCentre Hospitalier Universitaire de La Réunion · FRUniversité Côte d'Azur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Clefts of the lip and palate (CLP) are facial deformities that require multiple surgical procedures during childhood. One of these steps consists of filling the alveolar space with bone graft, traditionally removed from the iliac crest. However, this procedure could be invasive in children. Aim: Here, we aimed to evaluate the outcomes of GlassBONE™ graft, a bioactive glass used as a bone substitute, as an alternative to the deleterious autologous bone graft in children. Materials & methods: Retrospective monocentric study with 17 children aged 7.5 ± 2.2 yo [3.8-13.3 yo] carrying CLP. This technique has been established at La Timone Children hospital (Assistance Publique - Hôpitaux de Marseille) since 2011. Clinical (scar, graft rejection and periodontal status) and radiological (both panoramic radiographs and cone beam-CT) follow-up was conducted one year after the graft. The primary outcome was the reduction of the cleft volume, and secondary was the eruption of the adjacent tooth through the graft. Results: GlassBONE™ permitted a significant reduction in the cleft volume by 42.4 ± 27.7% [0.6-81.1%] ( Conclusion: The bioactive glass GlassBONE™ could be safely used in children with small CLP cases, providing satisfactory clinical and radiological results.

Indexed as

Bone transplantationCleft lipCleft palateGlassBONE™Oral surgery

Identifiers

PMID38601220
PMCPMC11001803
OpenAlexW4389045257

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.